Target intelligence / Profile preview

Lipid-derived peroxyl and alkoxyl radicals in polyunsaturated phospholipids (LOO•/LO•)

Target
LOO•/LO•
Molecular classification
Reactive oxygen species, Lipid radicals, Free radicals
01

Overview

Lipid-derived peroxyl (LOO•) and alkoxyl (LO•) radicals are highly reactive chemical intermediates generated during the autoxidation of polyunsaturated fatty acids (PUFAs) within cellular phospholipids (Conrad & Pratt, 2019). These radicals are the primary drivers of the lipid peroxidation chain reaction, where a single initiation event can lead to the destruction of numerous lipid molecules, compromising membrane integrity and function (Yin et al., 2011). In recent years, these radicals have been identified as the executioners of ferroptosis, a form of iron-dependent regulated cell death linked to various pathologies (Stockwell et al., 2017). Therapeutic strategies focus on radical-trapping antioxidants (RTAs) like Ferrostatin-1 or Vitamin E, which neutralize these radicals to halt the propagation of oxidative damage (Zilka et al., 2017). Targeting these species is particularly relevant in treating neurodegenerative diseases, stroke, and certain types of cancer where ferroptosis plays a critical role (Dixon et al., 2012). Understanding the kinetics and localization of these radicals is crucial for developing targeted therapies that can mitigate oxidative stress without disrupting essential redox signaling (Conrad & Pratt, 2019).

Other names
Lipid peroxyl radicalsLipid alkoxyl radicalsPhospholipid peroxyl radicalsPUFA-derived radicalsLipid hydroperoxide-derived radicals
02

Mechanism of action

Radical-trapping antioxidant (RTA) activity and chain-breaking inhibition of lipid peroxidation

03

Biological functions

Lipid peroxidationFerroptosisOxidative stress signalingMembrane degradation
04

Disease associations

Neurodegenerative diseaseCancerIschemia-reperfusion injuryAtherosclerosisInflammation
05

Safety considerations

Potential disruption of physiological redox signalingPoor metabolic stability of synthetic RTAsPotential pro-oxidant effects at high concentrations
06

Interacting drugs

Ferrostatin-1

4 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)4-hydroxynonenal (4-HNE)F2-isoprostanesC11-BODIPY 581/591 oxidation

Beyond the preview

Go deeper on Lipid-derived peroxyl and alkoxyl radicals in polyunsaturated phospholipids (LOO•/LO•).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipid-derived peroxyl and alkoxyl radicals in polyunsaturated phospholipids (LOO•/LO•).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call